Patients undergoing BRAF/MEK inhibitor therapy for melanoma more commonly experience VKH-like uveitis compared with other malignancy types.
Fitzpatrick skin type influences both characteristics and outcomes associated with uveal melanoma and conjunctival melanoma.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback